Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Ferring signs licensing agreement with Seikagaku for condoliase

Aug. 29, 2016

Researchers from Genentech identify novel potent and selective NIK inhibitors

Aug. 26, 2016

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Aug. 24, 2016

Novel compound E-6887 shows promise for treating lupus

Aug. 24, 2016

Gilead begins phase III program for filgotinib in rheumatoid arthritis

Aug. 23, 2016

Medshine Discovery discloses JAK inhibitors

Aug. 12, 2016

MPC-300-IV shows dose-related improvements in phase II trial in biologic refractory RA

Aug. 11, 2016

Ablynx reports topline phase IIb results for vobarilizumab in patients with rheumatoid arthritis

Aug. 10, 2016

Autologous BMC is safe and effective in treating patients with atrophic non-unions

Aug. 8, 2016

Omeros' lead MASP-3 inhibitor shows efficacy in arthritis model

Aug. 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...